CCL2 and CXCL10 are associated with poor outcome after intracerebral hemorrhage

Intracerebral hemorrhage carries a high mortality and survivors are frequently left with significant disability. Immunological mechanisms may play an important role in hemorrhage‐induced brain injury, however, research linking these mechanisms with clinical outcome remains limited. We aim to identify serum inflammatory mediators that are associated with outcome after intracerebral hemorrhage in order to translate data from experimental models to a patient cohort and identify potential targets worthy of reverse translation.

[1]  L. Latour,et al.  Distinct myeloid cell subsets promote meningeal remodeling and vascular repair after mild traumatic brain injury , 2018, Nature Immunology.

[2]  J. C. Love,et al.  Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage , 2017, The Journal of clinical investigation.

[3]  A. Nadimi,et al.  Circulatory Levels of C-X-C Motif Chemokine Ligands 1, 9, and 10 Are Elevated in Patients with Ischemic Stroke. , 2017, The Eurasian journal of medicine.

[4]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[5]  Emiri T. Mandeville,et al.  A free radical scavenger edaravone suppresses systemic inflammatory responses in a rat transient focal ischemia model , 2016, Neuroscience Letters.

[6]  O. Lindvall,et al.  Monocyte-Derived Macrophages Contribute to Spontaneous Long-Term Functional Recovery after Stroke in Mice , 2016, The Journal of Neuroscience.

[7]  B. Zhu,et al.  Hepatitis C virus infection induces elevation of CXCL10 in human brain microvascular endothelial cells , 2016, Journal of medical virology.

[8]  Shailesh Singh,et al.  Heme-Mediated Induction of CXCL10 and Depletion of CD34+ Progenitor Cells Is Toll-Like Receptor 4 Dependent , 2015, PloS one.

[9]  Sara G. Murray,et al.  Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation , 2015, Nature Communications.

[10]  M. Elkind,et al.  Monocyte Count and 30-Day Case Fatality in Intracerebral Hemorrhage , 2015, Stroke.

[11]  T. Kanda,et al.  Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica , 2015, PloS one.

[12]  Y. Quan,et al.  Protein-protein interaction network and mechanism analysis in ischemic stroke , 2014, Molecular medicine reports.

[13]  K. Pennypacker,et al.  Pro-Inflammatory Interferon Gamma Signaling is Directly Associated with Stroke Induced Neurodegeneration , 2014, Journal of Neuroimmune Pharmacology.

[14]  Hulun Li,et al.  Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10 , 2014, Journal of Neuroinflammation.

[15]  Qing-Wu Yang,et al.  Inflammation in intracerebral hemorrhage: From mechanisms to clinical translation , 2014, Progress in Neurobiology.

[16]  Michael T. Mullen,et al.  CCR2+Ly6Chi Inflammatory Monocyte Recruitment Exacerbates Acute Disability Following Intracerebral Hemorrhage , 2014, The Journal of Neuroscience.

[17]  J. Broderick,et al.  Peripheral monocyte count is associated with case fatality after intracerebral hemorrhage. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[18]  S. Tsirka,et al.  Monocyte chemoattractant protein-1 and the blood–brain barrier , 2014, Cellular and Molecular Life Sciences.

[19]  J. García-Castro,et al.  A role for the CXCR3/CXCL10 axis in Rasmussen encephalitis. , 2013, Pediatric neurology.

[20]  W. Schäbitz,et al.  Monocyte Chemoattractant Protein-1–Deficiency Results in Altered Blood–Brain Barrier Breakdown After Experimental Stroke , 2013, Stroke.

[21]  C. Trautwein,et al.  Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytes , 2013, Hepatology.

[22]  T. Möller,et al.  Thrombin induces release of proinflammatory chemokines interleukin-8 and interferon-&ggr;-induced protein-10 from cultured human fetal astrocytes , 2013, Neuroreport.

[23]  A. Wells,et al.  The Beginning of the End: CXCR3 Signaling in Late-Stage Wound Healing. , 2012, Advances in wound care.

[24]  J. P. McCoy,et al.  Effect of anticoagulants on multiplexed measurement of cytokine/chemokines in healthy subjects. , 2012, Cytokine.

[25]  R. Keep,et al.  Intracerebral haemorrhage: mechanisms of injury and therapeutic targets , 2012, The Lancet Neurology.

[26]  S. Tsirka,et al.  The CCL2‐CCR2 system affects the progression and clearance of intracerebral hemorrhage , 2012, Glia.

[27]  L. Sansing,et al.  Gr1+ Macrophages and Dendritic Cells Dominate the Inflammatory Infiltrate 12 h After Experimental Intracerebral Hemorrhage , 2012, Translational Stroke Research.

[28]  C. Warlow,et al.  A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project, 1981–86 , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[29]  A. Evans,et al.  Systemic chemokine levels, coronary heart disease, and ischemic stroke events , 2011, Neurology.

[30]  H. Tozaki-Saitoh,et al.  Astrocytic P2Y1 receptor is involved in the regulation of cytokine/chemokine transcription and cerebral damage in a rat model of cerebral ischemia , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  I. Moxon-Emre,et al.  Neutrophil Depletion Reduces Blood-Brain Barrier Breakdown, Axon Injury, and Inflammation After Intracerebral Hemorrhage , 2011, Journal of neuropathology and experimental neurology.

[32]  J. Montaner,et al.  Brain Perihematoma Genomic Profile Following Spontaneous Human Intracerebral Hemorrhage , 2011, PloS one.

[33]  A. Luster,et al.  CXCR3 ligands: redundant, collaborative and antagonistic functions , 2011, Immunology and cell biology.

[34]  C. Anderson,et al.  Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2010, Stroke.

[35]  I. Charo,et al.  CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice. , 2010, The Journal of clinical investigation.

[36]  P. M. Janssen,et al.  Comparison of Telephone and Face-to-Face Assessment of the Modified Rankin Scale , 2009, Cerebrovascular Diseases.

[37]  I. Vaartjes,et al.  Gender Differences in Mortality after Hospital Admission for Stroke , 2009, Cerebrovascular Diseases.

[38]  H. Davies,et al.  Expression of Chemokines and Their Receptors by Human Brain Endothelium: Implications for Multiple Sclerosis , 2009, Journal of neuropathology and experimental neurology.

[39]  E. Borden,et al.  Identification of interferon-beta-stimulated genes that inhibit angiogenesis in vitro. , 2008, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[40]  Xiaobing Jiang,et al.  The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10. , 2008, Vaccine.

[41]  Chad M. Miller,et al.  Genomic Profiles of Damage and Protection in Human Intracerebral Hemorrhage , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[42]  E. Chiquete,et al.  Grading Scale for Prediction of Outcome in Primary Intracerebral Hemorrhages , 2007, Stroke.

[43]  J. Losy,et al.  Serial measurements of levels of the chemokines CCL2, CCL3 and CCL5 in serum of patients with acute ischaemic stroke. , 2006, Folia neuropathologica.

[44]  F. Sharp,et al.  Brain Genomics of Intracerebral Hemorrhage , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[45]  R. Keep,et al.  Mechanisms of brain injury after intracerebral haemorrhage , 2006, The Lancet Neurology.

[46]  T. Olsen,et al.  Sex differences in stroke survival: 10-year follow-up of the Copenhagen stroke study cohort. , 2005, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[47]  D. Kolson,et al.  Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis. , 2004, The American journal of pathology.

[48]  G. Hansson,et al.  Chemokines and atherosclerosis , 2004, Annals of medicine.

[49]  R. Keep,et al.  Potential role of MCP-1 in endothelial cell tight junction `opening': signaling via Rho and Rho kinase , 2003, Journal of Cell Science.

[50]  W. Kuziel,et al.  Chemokine Expression by Glial Cells Directs Leukocytes to Sites of Axonal Injury in the CNS , 2003, The Journal of Neuroscience.

[51]  R. Cheung,et al.  Use of the Original, Modified, or New Intracerebral Hemorrhage Score to Predict Mortality and Morbidity After Intracerebral Hemorrhage , 2003, Stroke.

[52]  M. Gomis,et al.  Sex Differences in First-Ever Acute Stroke , 2003, Stroke.

[53]  C. Kase,et al.  Molecular signatures of brain injury after intracerebral hemorrhage , 2002, Neurology.

[54]  G. Manley,et al.  The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. , 2001, Stroke.

[55]  R. Keep,et al.  Acute inflammatory reaction following experimental intracerebral hemorrhage in rat , 2000, Brain Research.

[56]  H. Sarau,et al.  Identification and molecular characterization of rat CXCR3: receptor expression and interferon-inducible protein-10 binding are increased in focal stroke. , 2000, Molecular pharmacology.

[57]  M. Xue,et al.  Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death , 2000, Neuroscience Letters.

[58]  F. Barone,et al.  Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[59]  E. Kremmer,et al.  Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells , 1999, European journal of immunology.

[60]  P. Loetscher,et al.  Lymphocyte‐specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization , 1998, European journal of immunology.

[61]  T. Perneger.  What's wrong with Bonferroni adjustments , 1998, BMJ.

[62]  C. Mackay,et al.  The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.

[63]  R. Bravo,et al.  Defects in Macrophage Recruitment and Host Defense in Mice Lacking the CCR2 Chemokine Receptor , 1997, The Journal of experimental medicine.

[64]  K. Ley,et al.  Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[65]  O. Bagasra,et al.  The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. , 1997, Cytokine & growth factor reviews.

[66]  N. Kawai,et al.  Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. , 1996, Journal of neurosurgery.

[67]  W. Gong,et al.  Human recombinant monocyte chemotactic protein and other c‐c chemokines bind and induce directional migration of dendritic cells in vitro , 1996, Journal of leukocyte biology.

[68]  T Brott,et al.  The ABCs of measuring intracerebral hemorrhage volumes. , 1996, Stroke.

[69]  T. Springer,et al.  Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[70]  P. Sandercock,et al.  A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[71]  E. Appella,et al.  Human monocyte chemoattractant protein‐1 (MCP‐1) Full‐length cDNA cloning, expression in mitogen‐stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE , 1989, FEBS letters.

[72]  J. Ravetch,et al.  Biochemical characterization of a gamma interferon-inducible cytokine (IP-10) , 1987, The Journal of experimental medicine.

[73]  N. Kučić,et al.  Monocytes and monocyte chemoattractant protein 1 (MCP-1) as early predictors of disease outcome in patients with cerebral ischemic stroke , 2015, Wiener klinische Wochenschrift.